Filing Flows › International Stem Cell (ISCO) › Free cash flow
International Stem Cell (ISCO) free cash flow by quarter
International Stem Cell's free cash flow was $160K in Q2 2026 (second quarter 2026), +63% from Q1 2026. Over the last 5 quarters it ranged from $29K (Q4 2025) to $222K (Q1 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $160K | +63% | — |
| Q1 2026 | $98K | +238% | -56% |
| Q4 2025 | $29K | -37% | — |
| Q3 2025 | $46K | -79% | — |
| Q1 2025 | $222K | — | — |
Q2 2026 at a glance
International Stem Cell, Q2 2026: revenue $2.7M (+9% year over year), operating margin -1.3%, net loss $71K, operating cash flow $167K. The chart follows the revenue to costs, profit and cash.
Questions
What is International Stem Cell's free cash flow?
International Stem Cell's free cash flow was $160K in Q2 2026 (second quarter 2026), +63% from Q1 2026.
How has International Stem Cell's free cash flow changed?
Over the last 5 quarters it ranged from $29K (Q4 2025) to $222K (Q1 2025).
Q2 2026 results → · How International Stem Cell makes money →